NCT06445075: Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
- State
- Completed
- Phase
- Phase 2
- People
- 102 taking part
- Started
- 21 May 2024
- Primary completion
- 4 Mar 2025
- Arms
- Cohort 1
- Results
- None posted
- Papers
- doi:10.1038/s41591-026-04440-4
- 21 May 2024: Trial started
- 6 Jun 2024: Trial registered
- 17 Jun 2025: Trial completed